COVID-GRAM Critical Illness Risk Score
ورودیهای بالینی بیمار
حداقل ۱۸ — حداکثر ۱۲۰ • واحد: years
حداقل ۰ — حداکثر ۱۰ • واحد: count
حداقل ۰.۵ — حداکثر ۵۰ • واحد: ratio
حداقل ۱۰۰ — حداکثر ۲۰۰۰ • واحد: U/L
حداقل ۰.۱ — حداکثر ۲۰ • واحد: mg/dL
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk≤ 1.7
- Medium Risk1.7–40.4
- High Risk≥ 40.4
The COVID-GRAM Critical Illness Risk Score calculates predicting risk of critical illness (ICU admission, mechanical ventilation, or death) in hospitalized COVID-19 patients. Key inputs include chest xray abnormality. Scores guide determining acute hospital admission, emergency department discharge safety, or intensive care transfer. Routine clinical application promotes standardized evidence-based patient management.
Clinical Guidelines & Evidence
Predicts risk of critical illness (ICU admission, mechanical ventilation, or death) in hospitalized COVID-19 patients
Clinical Indication
The COVID-GRAM Critical Illness Risk Score is indicated for bedside clinical practice to support Predicts risk of critical illness (ICU admission, mechanical ventilation, or death) in hospitalized COVID-19 patients. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult and pediatric patients presenting with acute undifferentiated clinical complaints, trauma, or unstable vital signs. Clinical application is indicated across Emergency triage, acute resuscitation bays, observation units, and emergency trauma centers.
Limitations & Contraindications
Score calculations must never delay immediate life-saving airway stabilization, vascular access, or emergent surgical consult.
Clinical Pearls & Action Plan
Adherence to core ABCDE resuscitation principles and bedside clinical gestalt must take absolute precedence over numerical decision tools. Guideline pearl: Developed from 1590 patients in development cohort and 710 in validation cohort from China.
Risk Score = (X-ray abnormality × 27.1464) + (Age × 0.6139) + (Hemoptysis × 33.6210) + (Dyspnea × 14.0569) + (Unconsciousness × 34.4617) + (Number of comorbidities × 10.3826) + (Cancer history × 31.2211) + (Neutrophil-lymphocyte ratio × 1.25) + (LDH × 0.0534) + (Direct bilirubin × 3.0605). Risk = e^x / (1 + e^x)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| chest_xray_abnormality | string | Yes | Chest X-ray abnormality present |
| age | integer | Yes | Patient age in years(years) |
| hemoptysis | string | Yes | Presence of hemoptysis (coughing up blood) |
| dyspnea | string | Yes | Presence of dyspnea (shortness of breath) |
| unconsciousness | string | Yes | Presence of unconsciousness or altered mental status |
| number_of_comorbidities | integer | Yes | Number of comorbidities present(count) |
| cancer_history | string | Yes | History of cancer |
| neutrophil_lymphocyte_ratio | float | Yes | Neutrophil to lymphocyte ratio(ratio) |
| lactate_dehydrogenase | float | Yes | Lactate dehydrogenase (LDH) level(U/L) |
| direct_bilirubin | float | Yes | Direct bilirubin level(mg/dL) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| ≤ 1.7 | Low Risk | Low risk of critical illness |
| 1.7–40.4 | Medium Risk | Medium risk of critical illness |
| ≥ 40.4 | High Risk | High risk of critical illness |
Evidence-Based References (EBM)
- Liang W, Liang H, Ou L, Chen B, Chen A, Li C, et al. Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. JAMA Intern Med. 2020;180(8):1081-1089. doi:10.1001/jamainternmed.2020.2033DOI: 10.1001/jamainternmed.2020.2033